January 12, 2026 · Form 4 insider transaction
BEDU-ADDO FRANK bought 548,782 shares of PDS BIOTECHNOLOGY CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 50 days after the transaction.
The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.